(Q37127437)

18 August 2017

1 reference

title

Pharmacological treatment of pathologic aggression in children (English)

1 reference

18 August 2017

1 reference

Drew H Barzman

1

1 reference

18 August 2017

Robert L Findling

series ordinal

2

1 reference

18 August 2017

publication date

1 April 2008

1 reference

International Review of Psychiatry

18 August 2017

published in

1 reference

18 August 2017

volume

20

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

151-157

1 reference

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

A double-blind pilot study of risperidone in the treatment of conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

A 26-week open-label study of quetiapine in children with conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Typical neuroleptics in child and adolescent psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Further evidence of the reliability and validity of DSM-IV ODD and CD in preschool children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Validity of DSM-IV conduct disorder in 41/2-5-year-old children: a longitudinal epidemiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Risperidone in the management of disruptive behavior disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Trends in antipsychotic use in a Texas medicaid population of children and adolescents: 1996 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Risperidone in children with autism and serious behavioral problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders. Results of a 2-year extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Aggressive behaviour in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Psychopharmacologic treatment of aggressive preschoolers: a chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Early childhood intervention. A promising preventative for juvenile delinquency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

Trends in the Use of Typical and Atypical Antipsychotics in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260801887819

10.1080/09540260801887819

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference